Storyline
From the beginning to today
The experimental drug Rentosertib, developed by Insilico Medicine using artificial intelligence, showed a reduction in biological age by six years in 42 patients. The study revealed changes in six aging markers, although the results do not confirm actual rejuvenation or the drug's ability to extend life.
1 of 1 events
the editorial blocs represented in the collected reporting
4 of 7 blocs are not represented in the collected reporting.